Replies to post #16466 on MMRGlobal, Inc. (fka MMRF)

[MIKE2OO5]

thanks snow great news again!eom.

[EZ2]

Dr. Bruce Garrett, President and Chief Operating Officer of GRSworldwide (GRS), MMR's biotech consultants on its anti-CD20 antibody assets, based in Rockville, Maryland, said, "These assets could show promise for treating a variety of medical conditions, chief among them cancer, rheumatoid arthritis and potentially others. Based on existing data, GRS believes this particular formulary has the potential to become one of the best anti-CD20 monoclonal antibodies in its class."

If he is even "close" to right ~~~ this is a potential HUGE opportunity!